![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-and-cediprof-announce-exclusive-distribution-agreement-in-us/articleshow/98508332.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215565
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210754
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214959
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213709
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-10-2020-1591766845.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212037
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2019-1571893469.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210080
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211546
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211715
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211547
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205401
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211352
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205401
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210080
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210080
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209799
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207340
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-mydayis-amphetamine-aspartateamphetamine-sulfatedextroamphetamine-saccharatedextroamphetamine-sulfate-extended-release-capsules-1509424451.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207388
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-13apr2016-1460549225.pdf
http://www.prnewswire.com/news-releases/impax-receives-fda-approval-for-generic-version-of-adderall-xr-mixed-salts-of-a-single-entity-amphetamine-product-capsules-cii-300221210.html
https://www.pharmacompass.com/pdf/news/actavis-elizabeths-generic-dextroamp-saccharatesulfateamp-aspartatesulfate-approved-in-us-1455706106.pdf
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0566-2016&w=01202016&lang=eng
http://www.prnewswire.com/news-releases/mylan-launches-generic-adderall-tablets-300182073.html
https://www.pharmacompass.com/pdf/news/mylan-generic-dextroamp-saccharatesulfateamp-aspartatesulfate-approved-in-us-1447760130.pdf